Marcinkowska E, Manitius J. Nadciśnienie tętnicze – od rozpoznania do leczenia. Fam Med Prim Care Rev 2005; 7(2): 283––297.
Polakowska M, Piotrowski W. Czynniki socjoekonomiczne a występowanie nadciśnienia tętniczego na wsi i w mieście.Badanie WOBASZ . Med Ogólna 2010; 16(45): 2.
Zdrojewski T, Rutkowski M, Bandosz P, et al. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NAT POL 2011 Survey. Kardiol Pol 2013; 71(4): 381–392.
Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 2008; 52(5): 818–827.
Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365(9455): 217–223.
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ES H) and of the European Society of Cardiology (ES C). J Hypertens 2007; 25(6): 1105–1187.
Krzesiński P, Gielerak G, Kowal J. Impedance cardiography – a modern tool for monitoring therapy of cardiovascular diseases.Kardiol Pol 2009; 67: 65–71.
Sanidas EA , Grammatikopoulos K, Anastasiadis G, et al. Thoracic fluid content and impedance cardiography: a novel and promising noninvasive method for assessing the hemodynamic effects of diuretics in hypertensive patients. Hellenic J Cardiol 2009; 50(6): 465–471.
Siebert J. Kardiografia impedancyjna. Gdańsk: Via Medica; 2007: 48.
Sodolski T, Kutarski A. Impedance cardiography: a valuable method of evaluating haemodynamic parameters. Cardiol J 2007;14(2): 115–126.
Ventura HO, Taler SJ, Strobeck JE. Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic,prognostic, and therapeutic decision making. Am J Hypertens 2005; 18(2 Pt. 2): 26S–43S.
Alfie J, Galarza C, Waisman G. Noninvasive hemodynamic assessment of the effect of mean arterial pressure on the amplitude of pulse pressure. Am J Hypertens 2005; 18(2 Pt. 2): 60S–64S.
Ferrario CM, Basile J, Bestermann W, et al. The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension. Ther Adv Cardiovasc Dis 2007; 1(2): 113–118.
Smith RD , Levy P, Ferrario CM. Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension 2006; 47: 771–777.
Krzesiński P, Gielerak G, Kowal J, et al. Usefulness of impedance cardiography in optimisation of antihypertensive treatment in patients with metabolic syndrome: a randomised prospective clinical trial. Kardiol Pol 2012; 70(6): 599–607.
Abdelhammed AI , Smith RD , Levy P, et al. Noninvasive hemodynamic profiles in hypertensive subjects. Am J Hypertens 2005;18: 51S–59S.
Xiajuan Z, Ding D, Yanyan H, Zhen H. Impedance cardiographic hemodynamic variables and hypertension in elderly Han residents. Ups J Med Sci 2013; 118(2): 80–86.
Rada MA , Cuffaro PE, Galarza CR, et al. Predictive value of non-invasive hemodynamic measurement by means of impedance cardiography in hypertensive subjects older than 50 years of age. Clin Exp Hypertens 2014; 36(5): 280–284.
Krzesiński P, Gielerak G, Kowal J, et al. A „patient-tailored” treatment of hypertension with use of impedance cardiography:a randomized, prospective and controlled trial. Med Sci Monit 2013; 19: 242–250.